A desperate but determined group of parents raised millions through golf tournaments and cocktail parties to support research for drugs to fight cystinosis, a rare, fatal childhood disease. They were ecstatic when a pill called Procysbi was approved in 2013

Quick Read

So they’re starting their own. A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a mission-driven, not-for-profit generic drug company, Civica Rx, to take some control over the drug supply

Quick Read

One of science’s best tools for understanding obesity is debunking myths about metabolism

Quick Read

The group, Public Citizen, says in a letter dated Tuesday that the study’s protocol is also so “fundamentally flawed” that it will not produce reliable findings

Quick Read

“WHO is calling for free and secure access by all responders to the affected populations,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General

Quick Read

Ethical questions often emerge when treating patients’ pain with opioids or treating them for substance-use disorder—questions that do not arise in other parts of practice

Quick Read

Dependence is a special type of drug-related harm. It’s an adaptive phenomenon resulting from exposure to a centrally-active drug and defined by the development of withdrawal symptoms when the drug is removed or the dose lowered too quickly

Quick Read

Watch now – our Travis Rieder joins host Greta Van Susteren to discuss challenges related to opioid use and withdrawal.

Read More